Report Detail

Request for Sample of this report

Pharma & Healthcare Global Weight-loss Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4516893
    • |
  • 27 February, 2023
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Weight-loss Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Weight-loss Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Weight-loss Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market size and forecasts, by Type and by Sales Channels, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Weight-loss Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Weight-loss Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd and Swiss Research Labs Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Weight-loss Drugs market is split by Type and by Sales Channels. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channels in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liquid
Powder
Softgels
Pills
Others
Market segment by Sales Channels
Online Sales
Hospitals and Clinics
Pharmacy
Others
Major players covered
Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Weight-loss Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Weight-loss Drugs, with price, sales, revenue and global market share of Weight-loss Drugs from 2018 to 2023.
Chapter 3, the Weight-loss Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Weight-loss Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channels, with sales market share and growth rate by type, sales channels, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Weight-loss Drugs market forecast, by regions, type and sales channels, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Weight-loss Drugs.
Chapter 14 and 15, to describe Weight-loss Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Weight-loss Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Weight-loss Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Liquid
    • 1.3.3 Powder
    • 1.3.4 Softgels
    • 1.3.5 Pills
    • 1.3.6 Others
  • 1.4 Market Analysis by Sales Channels
    • 1.4.1 Overview: Global Weight-loss Drugs Consumption Value by Sales Channels: 2018 Versus 2022 Versus 2029
    • 1.4.2 Online Sales
    • 1.4.3 Hospitals and Clinics
    • 1.4.4 Pharmacy
    • 1.4.5 Others
  • 1.5 Global Weight-loss Drugs Market Size & Forecast
    • 1.5.1 Global Weight-loss Drugs Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Weight-loss Drugs Sales Quantity (2018-2029)
    • 1.5.3 Global Weight-loss Drugs Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk Weight-loss Drugs Product and Services
    • 2.1.4 Novo Nordisk Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Novo Nordisk Recent Developments/Updates
  • 2.2 Currax
    • 2.2.1 Currax Details
    • 2.2.2 Currax Major Business
    • 2.2.3 Currax Weight-loss Drugs Product and Services
    • 2.2.4 Currax Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Currax Recent Developments/Updates
  • 2.3 Ultimate life ltd
    • 2.3.1 Ultimate life ltd Details
    • 2.3.2 Ultimate life ltd Major Business
    • 2.3.3 Ultimate life ltd Weight-loss Drugs Product and Services
    • 2.3.4 Ultimate life ltd Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Ultimate life ltd Recent Developments/Updates
  • 2.4 Wolfson Berg Ltd
    • 2.4.1 Wolfson Berg Ltd Details
    • 2.4.2 Wolfson Berg Ltd Major Business
    • 2.4.3 Wolfson Berg Ltd Weight-loss Drugs Product and Services
    • 2.4.4 Wolfson Berg Ltd Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Wolfson Berg Ltd Recent Developments/Updates
  • 2.5 Swiss Research Labs Ltd.
    • 2.5.1 Swiss Research Labs Ltd. Details
    • 2.5.2 Swiss Research Labs Ltd. Major Business
    • 2.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Product and Services
    • 2.5.4 Swiss Research Labs Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Swiss Research Labs Ltd. Recent Developments/Updates
  • 2.6 Roar Ambition
    • 2.6.1 Roar Ambition Details
    • 2.6.2 Roar Ambition Major Business
    • 2.6.3 Roar Ambition Weight-loss Drugs Product and Services
    • 2.6.4 Roar Ambition Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Roar Ambition Recent Developments/Updates
  • 2.7 Health and Nutrition Ltd.
    • 2.7.1 Health and Nutrition Ltd. Details
    • 2.7.2 Health and Nutrition Ltd. Major Business
    • 2.7.3 Health and Nutrition Ltd. Weight-loss Drugs Product and Services
    • 2.7.4 Health and Nutrition Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Health and Nutrition Ltd. Recent Developments/Updates
  • 2.8 Abbott
    • 2.8.1 Abbott Details
    • 2.8.2 Abbott Major Business
    • 2.8.3 Abbott Weight-loss Drugs Product and Services
    • 2.8.4 Abbott Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Abbott Recent Developments/Updates
  • 2.9 Kellogg Company
    • 2.9.1 Kellogg Company Details
    • 2.9.2 Kellogg Company Major Business
    • 2.9.3 Kellogg Company Weight-loss Drugs Product and Services
    • 2.9.4 Kellogg Company Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Kellogg Company Recent Developments/Updates
  • 2.10 Glanbia PLC
    • 2.10.1 Glanbia PLC Details
    • 2.10.2 Glanbia PLC Major Business
    • 2.10.3 Glanbia PLC Weight-loss Drugs Product and Services
    • 2.10.4 Glanbia PLC Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Glanbia PLC Recent Developments/Updates
  • 2.11 Ajinomoto Co. Inc.
    • 2.11.1 Ajinomoto Co. Inc. Details
    • 2.11.2 Ajinomoto Co. Inc. Major Business
    • 2.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Product and Services
    • 2.11.4 Ajinomoto Co. Inc. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Ajinomoto Co. Inc. Recent Developments/Updates
  • 2.12 Kraft Heinz Company
    • 2.12.1 Kraft Heinz Company Details
    • 2.12.2 Kraft Heinz Company Major Business
    • 2.12.3 Kraft Heinz Company Weight-loss Drugs Product and Services
    • 2.12.4 Kraft Heinz Company Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Kraft Heinz Company Recent Developments/Updates
  • 2.13 GlaxoSmithKline PLC
    • 2.13.1 GlaxoSmithKline PLC Details
    • 2.13.2 GlaxoSmithKline PLC Major Business
    • 2.13.3 GlaxoSmithKline PLC Weight-loss Drugs Product and Services
    • 2.13.4 GlaxoSmithKline PLC Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 GlaxoSmithKline PLC Recent Developments/Updates
  • 2.14 Herbalife Nutrition Ltd.
    • 2.14.1 Herbalife Nutrition Ltd. Details
    • 2.14.2 Herbalife Nutrition Ltd. Major Business
    • 2.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Product and Services
    • 2.14.4 Herbalife Nutrition Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Herbalife Nutrition Ltd. Recent Developments/Updates
  • 2.15 PepsiCo
    • 2.15.1 PepsiCo Details
    • 2.15.2 PepsiCo Major Business
    • 2.15.3 PepsiCo Weight-loss Drugs Product and Services
    • 2.15.4 PepsiCo Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 PepsiCo Recent Developments/Updates
  • 2.16 Nestle
    • 2.16.1 Nestle Details
    • 2.16.2 Nestle Major Business
    • 2.16.3 Nestle Weight-loss Drugs Product and Services
    • 2.16.4 Nestle Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Nestle Recent Developments/Updates
  • 2.17 Amway Corp.
    • 2.17.1 Amway Corp. Details
    • 2.17.2 Amway Corp. Major Business
    • 2.17.3 Amway Corp. Weight-loss Drugs Product and Services
    • 2.17.4 Amway Corp. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Amway Corp. Recent Developments/Updates

3 Competitive Environment: Weight-loss Drugs by Manufacturer

  • 3.1 Global Weight-loss Drugs Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Weight-loss Drugs Revenue by Manufacturer (2018-2023)
  • 3.3 Global Weight-loss Drugs Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Weight-loss Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Weight-loss Drugs Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Weight-loss Drugs Manufacturer Market Share in 2022
  • 3.5 Weight-loss Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Weight-loss Drugs Market: Region Footprint
    • 3.5.2 Weight-loss Drugs Market: Company Product Type Footprint
    • 3.5.3 Weight-loss Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Weight-loss Drugs Market Size by Region
    • 4.1.1 Global Weight-loss Drugs Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Weight-loss Drugs Consumption Value by Region (2018-2029)
    • 4.1.3 Global Weight-loss Drugs Average Price by Region (2018-2029)
  • 4.2 North America Weight-loss Drugs Consumption Value (2018-2029)
  • 4.3 Europe Weight-loss Drugs Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Weight-loss Drugs Consumption Value (2018-2029)
  • 4.5 South America Weight-loss Drugs Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Weight-loss Drugs Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 5.2 Global Weight-loss Drugs Consumption Value by Type (2018-2029)
  • 5.3 Global Weight-loss Drugs Average Price by Type (2018-2029)

6 Market Segment by Sales Channels

  • 6.1 Global Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 6.2 Global Weight-loss Drugs Consumption Value by Sales Channels (2018-2029)
  • 6.3 Global Weight-loss Drugs Average Price by Sales Channels (2018-2029)

7 North America

  • 7.1 North America Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 7.2 North America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 7.3 North America Weight-loss Drugs Market Size by Country
    • 7.3.1 North America Weight-loss Drugs Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Weight-loss Drugs Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 8.2 Europe Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 8.3 Europe Weight-loss Drugs Market Size by Country
    • 8.3.1 Europe Weight-loss Drugs Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Weight-loss Drugs Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 9.3 Asia-Pacific Weight-loss Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Weight-loss Drugs Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Weight-loss Drugs Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 10.2 South America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 10.3 South America Weight-loss Drugs Market Size by Country
    • 10.3.1 South America Weight-loss Drugs Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Weight-loss Drugs Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Weight-loss Drugs Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
  • 11.3 Middle East & Africa Weight-loss Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Weight-loss Drugs Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Weight-loss Drugs Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Weight-loss Drugs Market Drivers
  • 12.2 Weight-loss Drugs Market Restraints
  • 12.3 Weight-loss Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Weight-loss Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Weight-loss Drugs
  • 13.3 Weight-loss Drugs Production Process
  • 13.4 Weight-loss Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Weight-loss Drugs Typical Distributors
  • 14.3 Weight-loss Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Weight-loss Drugs. Industry analysis & Market Report on Weight-loss Drugs is a syndicated market report, published as Global Weight-loss Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Weight-loss Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,257.28
    		4,885.92
    		6,514.56
    		547,682.40
    		821,523.60
    		1,095,364.80
    		290,545.20
    		435,817.80
    		581,090.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo